After Baycol, now what?

Journal article

I. Goldsmith, R. W. Newman and W. D. Dachman

P and T, Vol.27(5)

2002

Abstract

cerivastatin

ezetimibe

gemfibrozil

hydroxymethylglutaryl coenzyme A reductase inhibitor

lipid

low density lipoprotein

rosuvastatin

statine derivative

drug approval

drug industry

drug manufacture

drug safety

drug withdrawal

food and drug administration

human

lipid blood level

mortality

myalgia

note

postmarketing surveillance

rhabdomyolysis

1 Record Views